112th Day Of Lockdown

Maharashtra26766514900710695 Tamil Nadu147324973102099 Delhi115346932363446 Karnataka4407717391846 Gujarat43723305552070 Uttar Pradesh3972424981983 Telangana3774524840375 Andhra Pradesh3301917467408 West Bengal3283819931980 Rajasthan2557119169524 Haryana2262817090312 Madhya Pradesh1900513575673 Bihar1885313019143 Assam178081217451 Odisha14280986496 Jammu and Kashmir111736223195 Kerala8931443835 Punjab85115663213 Chhatisgarh4379327520 Jharkhand4225242836 Uttarakhand3686286750 Goa2753160718 Tripura218315382 Manipur167210200 Puducherry153182918 Himachal Pradesh130993810 Nagaland8963460 Chandigarh60044610 Arunachal Pradesh3871453 Meghalaya318462 Mizoram2381590 Sikkim211860
Lifestyle Health and Wellbeing 11 Aug 2019 Liver cancer related ...

Liver cancer related deaths can be reduced with Hepatitis C drugs

ANI
Published Aug 11, 2019, 1:39 pm IST
Updated Aug 11, 2019, 1:39 pm IST
Hepatitis C drugs can reduce liver-cancer related deaths: Study.
Curing hepatitis C with antivirals breaks the first link in a deadly chain of events and can lead to an improvement in liver function among those who have previously developed cirrhosis. (Photo: Representational/Pexels)
 Curing hepatitis C with antivirals breaks the first link in a deadly chain of events and can lead to an improvement in liver function among those who have previously developed cirrhosis. (Photo: Representational/Pexels)

Washington: A new study has put forth that antiviral drugs used to treat hepatitis C are beneficial in reducing liver-related deaths by nearly 50 per cent in patients who had a history of liver cancer. Findings of the study were published in the journal 'Gastroenterology'.

Many doctors previously believed that hepatitis C, for all its harmfulness, activates the immune system when it infects the liver, and the immune system kept liver cancer recurrence at bay.

 

But this notion appears to be false. In this study, researchers studied nearly 800 patients from 31 medical centers across the country and found that the drugs are not only safe, but they also decreased deaths from cirrhosis and liver cancer by 46 per cent.

"Not only are these drugs safe in this patient population, but we have now demonstrated that they are helpful," said Dr. Amit Singal, study author, associate professor of Internal Medicine, Medical Director of the UT Southwestern Liver Tumor Program, and Clinical Chief of Hepatology.

 

Dr. Caitlin Murphy said previous studies compounded the misunderstandings of direct-acting antiviral therapy because they, among other things, failed to account for the timing of therapy relative to liver cancer diagnosis, did not include a comparison group, or did not properly consider clinical differences among patients.

"Hepatitis C therapy is so important because it provides a cure," Dr. Singal said. "You take oral medications for two or three months, with minimal to no side effects, and you're done. You're cured of hepatitis C. There's less than a 1 per cent chance of relapse if you're cured of hepatitis C," he added.

 

Defeating hepatitis C is an important step because the infection can otherwise lead to cirrhosis scarring of the liver which can be deadly. Cirrhosis can increase the risk of liver cancer, which also may be fatal.

Curing hepatitis C with antivirals breaks the first link in a deadly chain of events and can lead to an improvement in liver function among those who have previously developed cirrhosis.

...




ADVERTISEMENT
ADVERTISEMENT
ADVERTISEMENT
ADVERTISEMENT
ADVERTISEMENT